Dr Tracy O'Mara and her team of researchers in Australia have made an important breakthrough in understanding risk factors for endometrial cancer. Their findings could go on to help people at high risk from developing endometrial cancer, and could shed light on new ways to treat patients with the disease.
This important breakthrough could lead to early detection, personalized interventions, and ultimately, improved outcomes for patients with endometrial cancer. This is crucial given the rising incidence and mortality rates of endometrial cancer. We cannot thank you enough for the trust you have placed in us to carry out this important work. Your contributions are making a real difference in the fight against cancer, and we are honoured to have your support.
Endometrial cancer happens when cells in the lining of the womb (the endometrium) start to grow out of control and spread. It is the most common type of womb cancer and is the 4th most common cancer in women in the UK.
Most cases of endometrial cancer are spotted because of irregular bleeding or bleeding after menopause. If caught early, endometrial cancer can often be treated effectively. However worryingly, the number of cases has been increasing in recent years in many countries.
This means that it’s more important than ever that we understand what factors make someone more at risk of endometrial cancer – because it could help us to prevent many cases from ever happening in the first place. Thanks to your support, Dr Tracy O’Mara and her team have been investigating which factors are more likely to be shared among patients with endometrial cancer.
They found five key factors that independently affect a person's risk of endometrial cancer: waist circumference, age at natural menopause, age at first period, levels of testosterone, and levels of sex-hormone binding globulin - a protein that attaches to sex hormones in the blood.
In the second part of their study, Dr O’Mara combined these findings with genetic information. They found a specific genetic sequence, which is the order of genes in a person’s DNA, that was linked to an increased risk of developing endometrial cancer.
Importantly, this sequence was also linked with testosterone levels, one of the five key risk factors that the team identified. Dr O’Mara believes that this could mean it is possible to prevent or treat endometrial cancer by targeting testosterone with hormone therapy, and that we could also use this knowledge to spot people at high risk. The team hope that this could be possible within the next five years.
By becoming a Curestarter, you can help us continue to support more bright ideas like Dr O'Mara's - allowing us to potentially uncover new knowledge about cancer that could lead to lifesaving new ways to prevent, diagnose, and treat cancer.
Donate now & become a Curestarter
Be part of a united effort to stop lives being cut short by cancer.
